MED 7, LLC ANNOUNCES GRANT OF US PATENT FOR CLINICAL USE.
BLUFFDALE, Utah, January 15, 2024 — Med 7, LLC (www.med7cbd.com) announces the recent granting of a US patent for Hempzorb81™, marking a significant milestone in the field of inflammation management. This groundbreaking patent highlights Med 7® as the first Full Spectrum CBD product to receive such recognition for its efficacy in addressing inflammation-related conditions. The […]